Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Gascón

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Biomed Research International|October 1, 2015
Biological and Pharmacological Aspects of the NK1-ReceptorSusana Garcia-Recio, Pedro Gascón
Current Drug Targets|May 11, 2010
Tyrosine kinase receptor transactivation associated to G protein-coupled receptorsVanessa Almendro, Susana García-Recio, Pedro Gascón
Biochimica Et Biophysica Acta|May 28, 2011
The neuronal influence on tumor progressionMario Mancino, Elisabet Ametller, Pedro Gascón, et al.
Clinical Immunology (Orlando, Fla.)|September 23, 2003
Defect in the lymphoid compartment might account for CD8+-mediated effects in the pathophysiology of pure red cell aplasiaPranela Rameshwar, Shakti H Ramkissoon, Selvaraj Sundararajan, et al.
Plos One|June 27, 2015
The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase ActivationSusana Garcia-Recio, Eva M Pastor-Arroyo, Mercedes Marín-Aguilera, et al.
Gynecologic Oncology|August 2, 2003
Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpusClara Montagut, Maribel Mármol, Victoria Rey, et al.
Cancer Biology & Therapy|October 29, 2010
Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell deathElisabet Ametller, Susana García-Recio, Eva-María Pastor-Arroyo, et al.
Oncotarget|December 18, 2015
Differential expression of neurogenes among breast cancer subtypes identifies high risk patientsPatricia Fernández-Nogueira, Paloma Bragado, Vanessa Almendro, et al.
Plos One|March 7, 2009
The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatinVanessa Almendro, Elisabet Ametller, Susana García-Recio, et al.
Molecular Cancer|June 25, 2010
Tumor promoting effects of CD95 signaling in chemoresistant cellsElisabet Ametller, Susana García-Recio, Domizziana Costamagna, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biomed Research International|October 1, 2015
Biological and Pharmacological Aspects of the NK1-ReceptorSusana Garcia-Recio, Pedro Gascón
Current Drug Targets|May 11, 2010
Tyrosine kinase receptor transactivation associated to G protein-coupled receptorsVanessa Almendro, Susana García-Recio, Pedro Gascón
Biochimica Et Biophysica Acta|May 28, 2011
The neuronal influence on tumor progressionMario Mancino, Elisabet Ametller, Pedro Gascón, et al.
Clinical Immunology (Orlando, Fla.)|September 23, 2003
Defect in the lymphoid compartment might account for CD8+-mediated effects in the pathophysiology of pure red cell aplasiaPranela Rameshwar, Shakti H Ramkissoon, Selvaraj Sundararajan, et al.
Plos One|June 27, 2015
The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase ActivationSusana Garcia-Recio, Eva M Pastor-Arroyo, Mercedes Marín-Aguilera, et al.
Gynecologic Oncology|August 2, 2003
Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpusClara Montagut, Maribel Mármol, Victoria Rey, et al.
Cancer Biology & Therapy|October 29, 2010
Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell deathElisabet Ametller, Susana García-Recio, Eva-María Pastor-Arroyo, et al.
Oncotarget|December 18, 2015
Differential expression of neurogenes among breast cancer subtypes identifies high risk patientsPatricia Fernández-Nogueira, Paloma Bragado, Vanessa Almendro, et al.
Plos One|March 7, 2009
The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatinVanessa Almendro, Elisabet Ametller, Susana García-Recio, et al.
Molecular Cancer|June 25, 2010
Tumor promoting effects of CD95 signaling in chemoresistant cellsElisabet Ametller, Susana García-Recio, Domizziana Costamagna, et al.
Pageof 2